This phenomenon is clearly observed in the STEP 2 trial of semaglutide (2.4 mg weekly), where a cumulative 33.7% of patients with obesity and T2D reported nausea throughout the duration of the trial ( It has been hypothesized that the deleterious, nauseating effects of GLP-1R agonists and the beneficial, food-intake reducing effects are inextricably linked
Like GLP-1, GIP stimulates insulin secretion from pancreatic cells in a glucose-dependent manner (124)
For regulatory context on light-based therapies, see the FDAs overview of light therapy devices
Start your intake How Berberine and Semaglutide Work on Different Metabolic Pathways Berberine, a plant alkaloid, exerts effects primarily through AMPK activation and mitochondrial function enhancement
Although much of the hair loss being reported after starting GLP-1 medications could be temporary telogen effluvium related to rapid weight loss or nutritional stress, he believes it is entirely plausible that in those genetically predisposed to androgenetic alopecia, [GLP-1s] may be triggering its early onset. Nusbaum, of the Miami Hair Institute, said he has started to see several patients with underlying androgenetic alopecia, which is male- or female-pattern hair loss, where that underlying condition is being exacerbated by the use of these medications. Androgenetic alopecia has a distinct pattern
In response, the government is focusing on health reforms and chronic disease management, driving the demand for anti-obesity medications
